SAN DIEGO, Aug. 29, 2012 /PRNewswire/ — Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, has announced that its portfolio company, Red Dice Holdings, is expanding distribution of its Dixie X, Hemp-based Cannabidiol (CBD) product line with shipments to medical marijuana dispensaries in two major markets: New Mexico and Oregon.
Since Dixie X is a Hemp-based product, it is legal in all 50 states and has the potential to help an unlimited number of patients and consumers throughout the United States. Studies have shown it may be effective in providing natural, safe relief for a variety of medical conditions including pain management, anxiety, nausea and convulsions. On September 5th, Red Dice Holdings will launch on-line sales of Dixie X products throughout the U.S., followed in 30 days by the launch of its CBD-infused CanChew gum products.
New Mexico first approved medical marijuana in 2007 and now has a total patient count of nearly 10,000 people. The State Department recently reported that 40 percent of medical marijuana patients list Post Traumatic Stress Disorder (PTSD) as their qualifying condition, more than any other condition approved by the state. Oregonians first approved medical marijuana in 1998, with regulations today that allow the state approved facilities to serve approximately 55,000 medical marijuana patients.
I am really excited to be carrying Dixie Elixir’s new high Cannabidiol (CBD) tinctures, capsules and salves. Double blind respected studies are finding benefits for a wide range of issues our patients suffer with on a daily basis, such as anxiety, arthritis, cancer, Crohn’s Disease, Multiple Sclerosis, Epilepsy, and Neurological Disorders, to name a few. These new CBD-rich options will even allow us to ship these important products anywhere without violating any federal laws,” said Zeke Shortes, Director of Sacred Garden located in Santa Fe, New Mexico.We are excited to begin marketing our Hemp Wellness CBD line of Dixie X products through these important and carefully selected partners in New Mexico and Oregon. These are states that have a large number of patients in need of a treatment option such as Dixie X that offers pain relief and other health benefits without the THC. The demand for these products has been overwhelming in advance of our scheduled launch on September 5th we are very excited for what the future holds,” said Tripp Keber, President and CEO of Red Dice Holdings.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About Sacred Garden
Sacred Garden is a compassionate care center located in Santa Fe, New Mexico. For more information about Sacred Garden visit: www.sacredgardennm.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana Inc.